It can suppress the transcriptional activity of CNBP, and it functions as an endogenous inhibitor for repressing the binding of CNBP to the HuR promoter, resulting in the downregulation of HuR and its target genes involved in cancer progression. This evidence concerns the gene ELAVL1 and cancer.